Back to Search Start Over

SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AGE-SPECIFIC REFERENCE VALUES FOR HEALTHY ADULT POPULATION OF SERBIA.

Authors :
Stojanovic, M.
Popevic, M.
Pekic, S.
Doknic, M.
Miljic, D.
Medic-Stojanoska, M.
Topalov, D.
Stojanovic, J.
Milovanovic, A.
Petakov, M.
Damjanovic, S.
Popovic, V.
Source :
Acta Endocrinologica (1841-0987). Oct-Dec2021, Vol. 17 Issue 4, p462-471. 10p.
Publication Year :
2021

Abstract

Context. Insulin-like growth factor-1 (IGF-1) is main serum surrogate marker of growth hormone (GH) secretion, used in diagnostics and treatment of GH deficiency (GHD) and acromegaly. Regional, ethnic, racial or nutritional factors obscure cross-population applicability of IGF-1 reference values. Establishment of population- and assayspecific reference values requires sizable representative cohort of healthy subjects. Subjects and Methods. In representative sample of healthy adult population of Serbia (N=1200, 21-80 years, 1:1 male:female) serum IGF-1 was analyzed by Siemens Immulite 2000 assay under uniform laboratory conditions. Upper and lower limit of reference range (5th - 95th percentile) were calculated for each of the 12 quinquennial age intervals. IGF-1 distribution was normalized and standard deviation score (SDS) calculated by Logarithmic and LMS methods. Results. IGF-1 and age correlated significantly, with most prominent decline at 21-50 years, followed by a plateau up to age of 70. Gender differences were not significant overall. Plateau in age-related IGF-1 decline was less prominent in women. Correlations of IGF-1 with body mass index (BMI) or waist to hip ratio (WHR) were insignificant. Superior IGF-1 SDS transformation was achieved with LMS method, while logarithmic method was simpler to use. Conclusions. Normative age-specific serum IGF-1 reference values were established on a representative cohort of healthy adults in Serbia. Our results support recommendations against necessity for gender-specific or BMI- and WHR-specific reference ranges. Populationbased data serve to generate IGF-1 SDS, which is valuable in rational application of consensus guidelines, proper longitudinal follow-up, advancement in efficacy and safety and personalization of treatment targets. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
18410987
Volume :
17
Issue :
4
Database :
Academic Search Index
Journal :
Acta Endocrinologica (1841-0987)
Publication Type :
Academic Journal
Accession number :
157428216
Full Text :
https://doi.org/10.4183/aeb.2021.462